CORT

CORCEPT THERAPEUTICS INC

CORT · CIK 1088856 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$761M
20182025
Net Income$100M
20182025
Operating CF$142M
20182025
Free Cash Flow$142M
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$0.8B$0.7B$0.5B$0.4B$0.4B$0.1B$0.1B$0.1B
Cost of Revenue$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Gross Profit—————$0.1B$0.1B$0.1B
R&D Expense$0.3B$0.2B$0.2B$0.1B$0.1B$0.1B$0.1B$0.1B
SG&A Expense$0.4B$0.3B$0.2B$0.2B$0.1B$0.1B$0.1B$0.1B
Operating Income$0.0B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B
Net Income$0.1B$0.1B$0.1B$0.1B$0.1B$0.0B$0.0B$0.0B
EPS (Basic)$0.95$1.35$1.02$0.95$0.97$0.22$0.26$0.19
EPS (Diluted)$0.82$1.23$0.94$0.87$0.89$0.20$0.24$0.18

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$0.8B$0.8B$0.6B$0.6B$0.4B$0.6B$0.4B$0.3B
Current Assets$0.5B$0.5B$0.5B$0.5B$0.3B$0.5B$0.3B$0.2B
Cash & Equivalents$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.0B$0.0B
Total Liabilities$0.2B$0.2B$0.1B$0.1B$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.2B$0.1B$0.1B$0.1B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.6B$0.7B$0.5B$0.5B$0.4B$0.5B$0.4B$0.3B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$0.1B$0.2B$0.1B$0.1B$0.2B$0.2B$0.1B$0.1B
Investing Cash Flow$0.1B$-0.2B$0.1B$-0.1B$0.1B$-0.1B$-0.1B$-0.1B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$-0.2B$-0.0B$-0.1B$-0.0B$-0.3B$0.0B$-0.0B$-0.0B
← Companies